Predicting compliance in a breast cancer prevention trial

Breast Journal

Volumn 12, Issue 5, 2006, Pages 446-450

  Maurice, Andrew ^a,b   Howell, Anthony ^a,c   Evans, D Gareth ^a,d   O'Neil, Alison C ^a   Scobie, Sue ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b Schoolhouse Surgery   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Chemoprevention trials; Compliance

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOPREVENTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; SELF ADMINISTRATION; TAMOXIFEN;

EID: 33748349012     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00295.x     Document Type: Article

References (13)

1. Nixon DW. Special aspects of cancer prevention trials. Cancer 1994;74(9 suppl):2683-86.
2. International Breast Cancer Intervention Study I (IBIS-I). London: Cancer Research UK.
3. Powles TJ, Jones AL, Ashley SE, et al. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 1989;14:23-31.
4. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998;352:93-97.
5. Fisher B, Costantino JP, Wickerham LD, et al. Tamoxifen for the prevention of breast cancer. Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Inst Cancer 1998;90:1371-88.
6. Pritchard KI. Is tamoxifen effective in prevention of breast cancer? Lancet 1998;352:80-81.
7. International Breast Cancer Intervention Study II (IBIS-II). London: Cancer Research UK.
8. Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts and microelectronic monitoring. J Clin Oncol 1993;11:1189-97.
9. Punchak SS, Goodyer LI. Recent developments in electronic monitoring aids in assessing compliance with medication. Hosp Pharmacy Pract 1992:167-69.
10. Matin KA, Bowen DJ, Dunbar-Jacob J, Perri MG. Who will adhere? Key issues in the study and prediction of adherence in randomised controlled trials. Control Clin Trials 2000;21(5 suppl.):195S-99S.
11. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10.
12. Ellis S, Schmaker S, Sieber W, Rand C. Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Control Clin Trials 2000;21(5 suppl.):218S-25S.
13. Anderson RT, Ory M, Cohen S, McBride JS. Issues of ageing and adherence to health interventions. Control Clin Trials 2000;21 (5 suppl.):171S-83S.